SELARL PHARMACIE MATTIONI BOURLARD : revenue, balance sheet and financial ratios

SELARL PHARMACIE MATTIONI BOURLARD is a French company founded 25 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MITRY-MORY (77290), this company of category PME shows in 2023 a revenue of 2.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE MATTIONI BOURLARD (SIREN 432563013)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C 2 898 123 € 3 057 057 € 2 708 861 € 2 383 803 € 2 282 198 € 2 223 953 € 2 229 077 € 2 287 759 €
Net income 306 469 € 345 967 € 485 992 € 358 084 € 270 450 € 296 216 € 255 134 € 239 420 € 224 425 €
EBITDA N/C 328 020 € 452 798 € 319 757 € 244 479 € 275 317 € 202 631 € 225 738 € 202 381 €
Net margin N/C 11.9% 15.9% 13.2% 11.3% 13.0% 11.5% 10.7% 9.8%

Revenue and income statement

In 2024, SELARL PHARMACIE MATTIONI BOURLARD generates positive net income of 306 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 224 k€ -> 306 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

306 469 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 191%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 28%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

190.826%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

28.044%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

2.8%

Solvency indicators evolution
SELARL PHARMACIE MATTIONI BOURLARD

Sector positioning

Debt ratio
190.83 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average +15 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE MATTIONI... (190.83) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
28.04% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch -12 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE MATTIONI... (28.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
1.88 years 2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Good +8 pts over 2 years

In 2023, the repayment capacity of SELARL PHARMACIE MATTIONI... (1.88) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 263.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

263.885

Liquidity indicators evolution
SELARL PHARMACIE MATTIONI BOURLARD

Sector positioning

Liquidity ratio
263.88 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent

In 2024, the liquidity ratio of SELARL PHARMACIE MATTIONI... (263.88) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
1.02x 2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average

In 2023, the interest coverage of SELARL PHARMACIE MATTIONI... (1.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 284 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 793 days. Excellent situation: suppliers finance 509 days of the operating cycle (retail model).

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

284 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

793 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE MATTIONI BOURLARD

Positioning of SELARL PHARMACIE MATTIONI BOURLARD in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE MATTIONI BOURLARD is estimated at 4 278 533 € (range 2 979 503€ - 6 400 931€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2979k€ 4278k€ 6400k€
4 278 533 € Range: 2 979 503€ - 6 400 931€
NAF 5 année 2024

Valuation method used

Net Income Multiple
306 469 € × 14.0x = 4 278 534 €
Range: 2 979 503€ - 6 400 931€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE MATTIONI BOURLARD with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE MATTIONI BOURLARD

What is the revenue of SELARL PHARMACIE MATTIONI BOURLARD ?

The revenue of SELARL PHARMACIE MATTIONI BOURLARD in 2023 is 2.9 M€.

Is SELARL PHARMACIE MATTIONI BOURLARD profitable?

Yes, SELARL PHARMACIE MATTIONI BOURLARD generated a net profit of 306 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE MATTIONI BOURLARD ?

The headquarters of SELARL PHARMACIE MATTIONI BOURLARD is located in MITRY-MORY (77290), in the department Seine-et-Marne.

Where to find the tax return of SELARL PHARMACIE MATTIONI BOURLARD ?

The tax return of SELARL PHARMACIE MATTIONI BOURLARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE MATTIONI BOURLARD operate?

SELARL PHARMACIE MATTIONI BOURLARD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.